Inventor · disambiguated record
Kevin N. Sill
Also filed as: SILL KEVIN · SILL KEVIN N
49 granted patents·30 pending applications·483 citations·filing 2005–2024
98Inventor score
Files withINTEZYNE TECHNOLOGIES INC23BREITENKAMP KURT8SILL KEVIN N8INTEZYNE TECH INC6MIROSEVICH JANNI6
Top patents by PatentIndex Score
79 records- 0198US7560588B2Poly(ethylene glycol) containing chemically disparate endgroupsINTEZYNE TECHNOLOGIES INC·Filed 2007·Granted Jul 14, 2009·39 cites·22 claims
- 0297US8263665B2Polymeric micelles for drug deliverySILL KEVIN N·Filed 2009·Granted Sep 11, 2012·66 cites·14 claims
- 0397US7638558B2Polymeric micelles for drug deliveryINTEZYNE TECHNOLOGIES INC·Filed 2006·Granted Dec 29, 2009·80 cites·14 claims
- 0496US8980326B2Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agentsSILL KEVIN N·Filed 2010·Granted Mar 17, 2015·14 cites·5 claims
- 0596US7799339B2Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agentsINTEZYNE TECHNOLOGIES INC·Filed 2008·Granted Sep 21, 2010·15 cites·1 claims
- 0695US11040993B2Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereofBOLD THERAPEUTICS INC·Filed 2020·Granted Jun 22, 2021·4 cites·31 claims
- 0795US10836869B1Polymer excipients for drug delivery applicationsTYNDALL FORMULATION SERVICES LLC·Filed 2020·Granted Nov 17, 2020·13 cites·3 claims
- 0895US7601796B2Synthesis of hybrid block copolymers and uses thereofINTEZYNE TECHNOLOGIES INC·Filed 2006·Granted Oct 13, 2009·23 cites·10 claims
- 0995US7589240B2Quantum dots tailored with electronically-active polymersUNIV MASSACHUSETTS·Filed 2005·Granted Sep 15, 2009·12 cites·8 claims
- 1094US11718754B2Poly(sarcosine) polymer excipientsCALUSA BIO LLC·Filed 2022·Granted Aug 8, 2023·2 cites·24 claims
- 1194US11692099B2Poly(sarcosine) polymer excipientsCALUSA BIO LLC·Filed 2022·Granted Jul 4, 2023·2 cites·20 claims
- 1294US8287910B2Polymeric micelles for polynucleotide encapsulationMIROSEVICH JANNI·Filed 2010·Granted Oct 16, 2012·47 cites·9 claims
- 1394US7618944B2Encapsulated amyloid-beta peptidesINTEZYNE TECHNOLOGIES INC·Filed 2008·Granted Nov 17, 2009·34 cites·10 claims
- 1493US11739111B2Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereofBOLD THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·2 cites·8 claims
- 1593US10918619B1Formulations of paclitaxel with poly(amino acid) block polymersTYNDALL FORMULATION SERVICES LLC·Filed 2020·Granted Feb 16, 2021·4 cites·7 claims
- 1693US10611787B2Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereofBOLD THERAPEUTICS INC·Filed 2018·Granted Apr 7, 2020·4 cites·7 claims
- 1791US11286344B2Polymer excipients for drug delivery applicationsTYNDALL FORMULATION SERVICES LLC·Filed 2020·Granted Mar 29, 2022·2 cites·15 claims
- 1891US9078930B2Block copolymers for stable micellesINTEZYNE TECHNOLOGIES INC·Filed 2013·Granted Jul 14, 2015·15 cites·14 claims
- 1990US8299128B2Compositions comprising polymeric micelles for drug deliverySILL KEVIN N·Filed 2010·Granted Oct 30, 2012·12 cites·23 claims
- 2090US8263663B2Azide functionalized peptide targeting groupsSILL KEVIN N·Filed 2010·Granted Sep 11, 2012·10 cites·1 claims
- 2189US8779008B2Polymeric micelles for drug deliveryINTEZYNE TECHNOLOGIES INC·Filed 2012·Granted Jul 15, 2014·9 cites·1 claims
- 2289US8426477B1Polymeric micelles for drug deliveryBREITENKAMP KURT·Filed 2012·Granted Apr 23, 2013·11 cites·1 claims
- 2389US8268936B2Synthesis of hybrid block copolymers and uses thereofBREITENKAMP KURT·Filed 2009·Granted Sep 18, 2012·8 cites·14 claims
- 2488US9499665B2Block copolymers for stable micellesINTEZYNE TECH INC·Filed 2015·Granted Nov 22, 2016·6 cites·1 claims
- 2588US8609146B2Multi-block copolymers for the preparation of stabilized micellesINTEZYNE INC·Filed 2012·Granted Dec 17, 2013·10 cites·1 claims
- 2687US9944752B2Block copolymers for stable micellesINTEZYNE TECH INC·Filed 2016·Granted Apr 17, 2018·2 cites·4 claims
- 2787US8747904B2Polymeric micelles for polynucleotide encapsulationMIROSEVICH JANNI·Filed 2012·Granted Jun 10, 2014·7 cites·22 claims
- 2887US2025129118A1Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 2986US12415825B2Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereofBOLD THERAPEUTICS INC·Filed 2023·Granted Sep 16, 2025·0 cites·9 claims
- 3085US8207353B2Poly(ethylene glycol) containing chemically disparate endgroupsSILL KEVIN N·Filed 2010·Granted Jun 26, 2012·3 cites·1 claims
- 3185US8066824B2Covalent modification of metal surfacesBREITENKAMP KURT·Filed 2007·Granted Nov 29, 2011·9 cites·11 claims
- 3284US2023312927A1Poly(sarcosine) polymer excipientsCALUSA BIO LLC·Filed 2023·Application pending·0 cites
- 3381US9944754B2Block copolymers for stable micellesINTEZYNE TECH INC·Filed 2016·Granted Apr 17, 2018·2 cites·8 claims
- 3480US11891482B2Polymer excipients for drug delivery applicationsTYNDALL FORMULATION SERVICES LLC·Filed 2022·Granted Feb 6, 2024·0 cites·18 claims
- 3580US7893277B2Poly(ethylene glycol) containing chemically disparate endgroupsINTEZYNE TECHNOLOGIES INC·Filed 2009·Granted Feb 22, 2011·2 cites·1 claims
- 3679US10143689B2SN-38 loaded iron crosslinked micelle and methods thereofINTEZYNE TECH INC·Filed 2018·Granted Dec 4, 2018·2 cites·16 claims
- 3779US10047197B2Block copolymers for stable micellesINTEZYNE TECH INC·Filed 2016·Granted Aug 14, 2018·2 cites·13 claims
- 3878US12173087B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Dec 24, 2024·0 cites·18 claims
- 3977US8524784B2Polymer micelles containing anthracylines for the treatment of cancerSILL KEVIN N·Filed 2010·Granted Sep 3, 2013·1 cites·11 claims
- 4077US8258190B2Encapsulated contrast agentsSKAFF HABIB·Filed 2008·Granted Sep 4, 2012·2 cites·15 claims
- 4174US11230568B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jan 25, 2022·0 cites·18 claims
- 4273US9441013B2Melanocortin 1 receptor ligands and methods of useGILLIES ROBERT J·Filed 2012·Granted Sep 13, 2016·2 cites·16 claims
- 4373US8629186B2Polymer micelles containing anthracyclines for the treatment of cancerINTEZYNE TECHNOLOGIES INC·Filed 2013·Granted Jan 14, 2014·3 cites·10 claims
- 4473US7612153B2Heterobifunctional poly(ethylene glycol) and uses thereofINTEZYNE TECHNOLOGIES INC·Filed 2005·Granted Nov 3, 2009·2 cites·23 claims
- 4569US2010136063A1Immunotherapy for Treatment of Amyloid-Related Disorders Using Encapsulated Beta-Amyloid PeptidesUNIV SOUTH FLORIDA·Filed 2009·Application pending·0 cites
- 4667US10857147B2SN-38 loaded iron crosslinked micelle and methods thereofINTEZYNE TECH INC·Filed 2018·Granted Dec 8, 2020·0 cites·20 claims
- 4764US2009275782A1Quantum Dots Tailored with Electronically-Active PolymersEMRICK TODD S·Filed 2009·Application pending·0 cites
- 4863US2024180844A1Particle compositions comprising polysarcosine lipid conjugatesCALUSA BIO LLC·Filed 2023·Application pending·0 cites
- 4962US11857630B2Formulations of SN-38 with poly(amino acid) block polymersTYNDALL FORMULATION SERVICES LLC·Filed 2021·Granted Jan 2, 2024·0 cites·36 claims
- 5062US2015232616A1Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agentsINTEZYNE TECHNOLOGIES INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →